The main factors favouring the choice of NAC are a high ratio between the tumor volume and the breast volume, the presence of lymph node metastases, the young age of the patient and some histological parameters including the high tumor grading and the presence of specific molecular subtypes such as Triple Negative and HER2+ tumors2. The gene discussed is ERBB2; the disease is neoplasm.